Literature DB >> 3922223

The clinical spectrum of alpha-L-iduronidase deficiency.

M Roubicek, J Gehler, J Spranger.   

Abstract

We present five patients with alpha-L-iduronidase deficiency who do not have the typical Hurler or Scheie phenotypes; they are compared to 28 similarly atypical cases from the literature. Phenotypic differences are pointed out and intrafamilial similarities stressed. Among the various possible explanations for this situation, the existence of genetic compounds seems acceptable for some of the cases, but others seem to be caused by different mutations. The elucidation of these alternative possibilities from recent biochemical research is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922223     DOI: 10.1002/ajmg.1320200308

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Authors:  A Hinek; S E Wilson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Hurler-Scheie phenotype associated with consanguinity.

Authors:  D L Davies; G N Dutton; J Farquharson; R W Logan; J L Tolmie
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Growth patterns in children with mucopolysaccharidosis I and II.

Authors:  Agnieszka Różdżyńska-Świątkowska; Agnieszka Jurecka; Joachim Cieślik; Anna Tylki-Szymańska
Journal:  World J Pediatr       Date:  2014-11-20       Impact factor: 2.764

4.  Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation.

Authors:  C Navarro; C Dominguez; M Costa; J J Ortega
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study.

Authors:  Grzegorz Wegrzyn; Julianna Kurlenda; Anna Liberek; Anna Tylki-Szymanska; Barbara Czartoryska; Ewa Piotrowska; Joanna Jakóbkiewicz-Banecka; Alicja Wegrzyn
Journal:  BMC Pediatr       Date:  2005-05-09       Impact factor: 2.125

6.  A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I.

Authors:  Daniel C Mendez; Alexander E Stover; Anthony D Rangel; David J Brick; Hubert E Nethercott; Marissa A Torres; Omar Khalid; Andrew Ms Wong; Jonathan D Cooper; James V Jester; Edwin S Monuki; Cian McGuire; Steven Q Le; Shih-Hsin Kan; Patricia I Dickson; Philip H Schwartz
Journal:  Mol Ther Methods Clin Dev       Date:  2015-02-11       Impact factor: 6.698

7.  Ultrasonographic Features of Hip Joints in Mucopolysaccharidoses Type I and II.

Authors:  Zbigniew Żuber; Agnieszka Jurecka; Agnieszka Różdżyńska-Świątkowska; Agata Migas-Majoch; Agnieszka Lembas; Beata Kieć-Wilk; Anna Tylki-Szymańska
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

8.  An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life.

Authors:  Sandra D K Kingma; Eveline J Langereis; Clasine M de Klerk; Lida Zoetekouw; Tom Wagemans; Lodewijk IJlst; Ronald J A Wanders; Frits A Wijburg; Naomi van Vlies
Journal:  Orphanet J Rare Dis       Date:  2013-07-09       Impact factor: 4.123

9.  alpha-L-iduronidase therapy for mucopolysaccharidosis type I.

Authors:  Jakub Tolar; Paul J Orchard
Journal:  Biologics       Date:  2008-12

Review 10.  Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure.

Authors:  Eveline J Langereis; Andrea Borgo; Ellen Crushell; Paul R Harmatz; Peter M van Hasselt; Simon A Jones; Paula M Kelly; Christina Lampe; Johanna H van der Lee; Thierry Odent; Ralph Sakkers; Maurizio Scarpa; Matthias U Schafroth; Peter A Struijs; Vassili Valayannopoulos; Klane K White; Frits A Wijburg
Journal:  Orphanet J Rare Dis       Date:  2013-10-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.